The independent source for health policy research, polling, and news.
201 - 220 of 1,309 Results
吃瓜不打烊 and California Healthline staffers made the rounds on national and local media this week to discuss their stories. Here鈥檚 a collection of their appearances.
It's been more than a year since the FDA declared a national shortage of Adderall, and it鈥檚 affecting more than just patients with ADHD. Those with narcolepsy, a much rarer condition, are often treated with the same medication. Without it, they're often unable to drive or function as usual.
2023 was another busy year in health care. As the covid-19 pandemic waned, policymakers looked anew at long-standing obstacles to obtaining and paying for care in the nation鈥檚 health care system. Meanwhile, abortion has continued to be an issue in much of the nation, as states respond to the Supreme Court鈥檚 2022 decision overturning the constitutional right to the procedure. This week, Rachel Cohrs of Stat, Sandhya Raman of CQ Roll Call, and Joanne Kenen of Johns Hopkins University and Politico Magazine join 吃瓜不打烊 chief Washington correspondent Julie Rovner to discuss these issues and wrap up the year in health. Also this week, Rovner interviews 吃瓜不打烊鈥 Jordan Rau about his joint 吃瓜不打烊-New York Times series 鈥淒ying Broke.鈥
In the past year, opioid settlement money has gone from an emerging funding stream for which people had lofty but uncertain aspirations to a coveted pot of billions being invested in remediation efforts. Here are some important and evolving factors to watch going forward.
Stories of chronic pain, drug-hopping, and insurance meddling are all too common among patients with rheumatoid arthritis. Precision medicine offers new hope.
Colorado officials say they haven鈥檛 been able to stand up a program to import drugs from Canada because of drugmaker opposition 鈥 and the Biden administration鈥檚 inaction.
吃瓜不打烊 gives readers a chance to comment on a recent batch of stories.
States and counties look to expand programs that accept donations of unused surplus drugs from places like nursing homes and hospitals and redistribute them to low-income and uninsured residents.
The Supreme Court heard arguments over whether the Sacklers, the family behind Purdue Pharma 鈥 which marketed OxyContin 鈥 could claim immunity from future lawsuits without claiming bankruptcy.
Despite the prevalence of autoimmune conditions, like the thyroid disease Hashimoto鈥檚, sometimes finding help can prove frustrating as well as expensive. There are often no definitive diagnostic tests, so patients may rack up big bills as they search for confirmation of their condition and for treatment options.
Florida鈥檚 Republican Gov. Ron DeSantis and California鈥檚 Democratic Gov. Gavin Newsom will square off in a first-of-its-kind debate on Nov. 30. 吃瓜不打烊 compared the political rivals鈥 health care positions, showing how their policies have helped 鈥 or hindered 鈥 the health of their states鈥 residents.
The prevalence of synthetic drugs is undercutting a previously effective and widely embraced opioid use disorder treatment tactic. Now, the model pioneered in Vermont a decade ago and adopted at sites nationwide, especially in hard-to-reach rural areas, is being forced to evolve.
吃瓜不打烊 and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here鈥檚 a collection of their appearances.
California鈥檚 Medicaid program is making it easier for people with diabetes to obtain the supplies and equipment they need to manage their blood sugar, partly by relaxing preauthorization requirements that can cause life-threatening delays.
A rule taking effect Jan. 1 was intended to stop one set of abuses by pharmacy benefit managers, or PBMs, but some pharmacists say it鈥檚 enabling these price brokers to simply do new things unfairly.
Supply problems, a high price tag, and bureaucratic obstacles are slowing the distribution of a therapy that can protect infants from the respiratory syncytial virus. That will leave them unnecessarily at risk of hospitalization this winter, pediatricians fear.
The government has proposed that Medicare fully cover preexposure prophylaxis drugs that prevent HIV, a change that could help America catch up with nations in Europe and Africa that are on track to end new infections decades before the U.S. under its current approach.
漏 2026 KFF